Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternatives to human heart replacement

T X Aufiero1, R C Reddy, J A Magovern

  • 1Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, USA.

Current Opinion in Cardiology
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain.

Journal of clinical pharmacy and therapeutics·2015
Same author

Sex differences in expression of oestrogen receptor α but not androgen receptor mRNAs in the foetal lamb brain.

Journal of neuroendocrinology·2014
Same author

Traditional fish intake and fatty acid composition in fish consuming and non-fish consuming populations.

Asia Pacific journal of clinical nutrition·2014
Same author

Inhaled corticosteroids for asthma: are they all the same?

Journal of clinical pharmacy and therapeutics·2009
Same author

Severe asthma: approach and management.

Postgraduate medical journal·2008
Same author

Cardiac fibroblasts influence cardiomyocyte phenotype in vitro.

American journal of physiology. Cell physiology·2007
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
See all related articles

The shortage of donor hearts drives innovation in xenotransplantation, ventricular assist devices, and cardiomyoplasty. These alternative cardiac therapies show promising advancements for patients awaiting heart transplantation.

Area of Science:

  • Cardiovascular research
  • Surgical innovation
  • Transplantation medicine

Background:

  • Growing disparity between donor heart availability and patient need for cardiac transplantation.
  • Urgent requirement for alternative solutions to address the donor heart shortage.

Purpose of the Study:

  • To review recent advancements in xenotransplantation, mechanical assist devices, and cardiomyoplasty.
  • To assess the current status and future potential of these alternative cardiac therapies.

Main Methods:

  • Review of experimental xenotransplantation results.
  • Evaluation of the development stage of implantable ventricular assist devices.
  • Analysis of progress in cardiomyoplasty techniques, indications, and patient selection.

Related Experiment Videos

Main Results:

  • Experimental xenotransplantation shows slow but steady improvement, with potential for near-future clinical trials.
  • Implantable ventricular assist devices are nearing a stage for permanent implantation with reasonable patient survival.
  • Cardiomyoplasty research is progressing in defining indications and confirming benefits.

Conclusions:

  • Xenotransplantation, ventricular assist devices, and cardiomyoplasty represent viable alternative strategies for end-stage heart failure.
  • Continued research and development in these fields are crucial to overcome donor heart scarcity.
  • These alternative cardiac therapies hold significant promise for improving patient survival and quality of life.